NeoGenomics Appoints Bill Bonello as Vice President, Treasurer, and Director of Corporate Development
Press Release
Read More
Wild-type blocking PCR combined with direct sequencing as a highly sensitive method for detection of low-frequency somatic mutations
Literature
Read More
Correlation Between MET Gene Amplification and TP53 Mutation in Upregulating PD-L1 Expression in EGFR-Wild-Type Lung Cancer
Literature
Read More
NeoGenomics and Definiens Enter Into Agreement to Develop Novel Assays for Clinical Trials & Clinical Testing
Press Release
Read More
NeoGenomics Reports 122% Revenue Growth to $60.5 Million and 11% Reduction in Average Cost per Test in the Fourth Quarter of 2016
Press Release
Read More
Using high-sensitivity sequencing for the detection of mutations in BTK and PLCγ2 genes in cellular and cell-free DNA and correlation with progression in patients treated with BTK inhibitors
Literature
Read More